Role of endotoxemia in cardiovascular dysfunction and lethality: Virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock

Infection and Immunity

Volumn 64, Issue 2, 1996, Pages 406-412

  Huffman, William D ^a   Danner, Robert L ^a   Quezado, Zenaide M N ^a   Banks, Steven M ^a   Elin, Ronald J ^a   Hosseini, Jeanette M ^a   Natanson, Charles ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DOG; ENDOTOXEMIA; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HEMODYNAMICS; LETHALITY; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; STRAIN DIFFERENCE;

EID: 0030071446     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.2.406-412.1996     Document Type: Article

References (47)

1. Andersen, B. M., F. Skjorten, and O. Solberg. 1979. Electron microscopical study of Neisseria meningitidis releasing various amounts of free endotoxin. Acta Pathol. Microbiol. Scand 87:109-115.
2. Andersen, B. M., and O. Solberg. 1984 Endotoxin liberation and invasivity of Neisseria meningitidis Scand. J. Infect Dis 16:247-254
3. Baumgartner, J. D. 1990. Monoclonal anti-endotoxin antibodies for the treatment of gram-negative bacteremia and septic shock Eur. J. Clin Microbiol Infect Dis. 9:711-716
4. Baumgartner, J. D. 1991. Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal Infect Dis Clin. North Am 5:915-927.
5. Brandtzaeg, P., P. Kierulf, P. Gaustad, A. Skulberg, J. N. Bruun, S. Halvorsen, and E. Sorensen. 1989. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect Dis. 159:195-204.
6. Brigham, K. L., R. E. Bowers, and J. Haynes. 1979. Increased sheep lung vascular permeability caused by Escherichia coli endotoxin. Circ. Res 45: 292-297
7. Brues, A. M., and M. J. Shear. 1944. Chemical treatment of tumors. X. Reactions of four patients with advanced malignant tumors to injection of a polysaccharide from Serratia marcescens culture filtration. J. Natl. Cancer Inst 5:195-208
8. Cavalieri, S. J., G. A. Bohach, and I. S. Snyder. 1984. Escherichia coli and alpha hemolysin. characteristics and probable role in pathogenicity. Microbiol. Rev 48:326-343.
9. Danner, R. L., R. J. Elin, J. M. Hosseini, R. A. Wesley, and J. E. Parrillo. 1991 Endotoxemia in human septic shock. Chest 99:169-175
10. Danner, R. L., C. Natanson, R. J. Elin, J. M. Hosseini, S. Banks, T. J. MacVittie, and J. E. Parrillo. 1990. Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia hut more cardiovascular dysfunction and mortality in a canine model of septic shock. Chest 98:1480-1487.
11. Demonty, J., and J. De Graeve. 1982. Release of endotoxic lipopolysaccharide by sensitive strains of Escherichia coli submitted to the bactericidal action of human serum. Med. Microbiol. Immunol. 170:265-277.
12. Eisenstein, B. I., and G. W. Jones. 1988. The spectrum of infections and pathogenic mechanisms of Escherichia coli. Adv Intern. Med. 33:231-252.
13. Elin, R. J., A. L. Sandberg, and D. L. Rosenstreich. 1976. Comparison of the pyrogenicity, limulus activity, mitogenicity and complement reactivity of several bacterial endotoxins and related compounds. J. Immunol 117:1238-1242.
14. Fine, J. 1954. The bacterial factor in traumatic shock. In I. H. Page and A. C Corcoran (ed.), American lecture series: monograph in American lectures in circulation, publication no. 219. Thomas, Springfield, Ill.
15. Fink, M. P., J. B. Antonsson, H. L. Wang, and H. R. Rothschild. 1991. Increased intestinal permeability in endotoxic pigs: mesenteric hypoperfusion as an etiologic factor. Arch. Surg. 126:211-218.
16. Fugger, R., G. Hamilton, M. Rogy, F. Herbst, W. Kwasny, M. Sehemper, and F. Schultz. 1990 Prognostic significance of endotoxin determination in patients with severe intraabdominal infection. J. Infect. Dis. 161:1314-1315.
17. Greenman, H. L., R. M. Sehein, M. A. Martin, R. P. Wenzel, N. R. MacIntyre, G. Emmanuel, H. Chmel, R. B. Kohler, M. McCarthy, J. Plouffe, J. A. Russell, and the XOMA Sepsis Study Group. 1991. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis JAMA 266:1097-1102.
18. Greisman, S. E., and W. E. Woodward. 1965. Mechanisms of endotoxin tolerance III The refractory state during continuous intravenous infusions of endotoxin J. Exp Med. 121:911-933.
19. Guidet, B., V. Barakett, T. Vassal, J. C. Petit, and G. Offenstadt. 1994. Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit Chest 106:1194-1201
20. Hoffman, W. D. 1994. Anti-endotoxin therapies in septic shock, p. 772-775. In C Natanson (ed ), Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann. Intern. Med. 120:771-783.
21. Huffman, W. D., and C. Natanson. 1993. Endotoxin in septic shock. Anesth. Analg. 77:613-624.
22. Johnson, J. R. 1991 Virulence factors in Escherichia coli urinary tract infections. Clin. Microbiol. Rev 4:80-120.
23. Jorgensen, J. H. 1986 Clinical applications of the limulus amebocyte lysate test, p 127-160. In R. A Proctor (ed ). Clinical aspects of endotoxin shock (Handbook of endotoxin. vol. 4). Elsevier, Amsterdam.
24. Kikeri, D., J. P. Pennell, K. H. Hwang, A. I. Jacob, A. V. Richman, and J. J. Bourgoignie. 1986. Endotoxemic acute renal failure in awake rats. Am. J. Physiol 250:F1098-F1106
25. Mattsby-Baltzer, I., K. Lindgren, B. Lindholm, and L. Edebo. 1991. Endotoxin shedding by enterobacteria: free and cell-bound endotoxin differ in Limulus activity. Infect. Immun 59:689-695
26. McCloskey, R. V., R. C. Straube, C. Sanders, S. M. Smith, and C. R. Smith. 1994 Treatment of septic shock with human monoclonal antibody HA-1A. a randomized, double-blind, placebo-controlled trial. Ann Intern. Med. 121: 1-5.
27. Mellado, M. C., R. Rodríguez-Contreras, M. Fernandez-Crehuet, R. Lopez-Gigosos, M. Delgado Rodriguez, and R. Galvez-Vargas. 1991. Endotoxin liberation by strains of N. meningitidis isolated from patients and healthy carriers Epidemiol. Infect 106:289-295.
28. Natanson, C., R. L. Danner, R. J. Elin, J. M. Hosseini, K. W. Peart, S. M. Banks, T. J. MacVittie, R. I. Walker, and J. E. Parrillo. 1989. The role of endotoxemia in cardiovascular dysfunction and mortality E. coli and S aureus challenges in a canine model of human septic shock. J. Clin. Invest 83:243-251.
29. Natanson, C., R. L. Danner, J. M. Reilly, M. L. Doerfler, W. D. Hoffman, G. L. Akin, J. M. Hosseini, S. M. Banks, R. J. Elin, T. J. MacVittie, and J. E. Parrillo. 1990 Antibiotics versus cardiovascular support in a canine model of human septic shock. Am. J. Physiol 259:H1440-H1447.
30. Natanson, C., P. W. Eichenholz, R. L. Danner, P. Q. Eichacker, W. D. Hoffman, G. C. Kuo, S. M. Banks, T. J. MacVittie, and J. E. Parrillo. 1989 Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J. Exp. Med. 169:823-832.
31. Natanson, C., M. Fink, H. Ballantyne, J. Conklin, T. J. MacVittie, and J. E. Parrillo. 1986. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J. Clin. Invest. 78:259-270
32. O'Dwyer, S. T., H. R. Michie, T. R. Ziegler, A. Revhaug, R. J. Smith, and D. W. Wilmore. 1988. A single dose of endotoxin increases intestinal permeability in healthy humans. Arch. Surg. 123:1459-1464
33. Parker, M. M., J. H. Shelhamer, S. L. Bacharach, M. V. Green, C. Natanson, T. M. Frederick, B. A. Damske, and J. E. Parrilio. 1984. Profound but reversible myocardial depression in patients with septic shock Ann. Intern Med 100:483-490.
34. Ravin, H. A., D. Rowley, C. Jenkins, and J. Fine. 1960. On the absorption of bacterial endotoxin from the gastrointestinal tract of normal and shocked animals. J. Exp. Med. 112:783-792.
35. Scheffe, H. 1959. The analysis of variance, p. 124-137. John Wiley & Sons. Inc., New York.
36. Shwartzman, G. 1928. Studies on Bacillus typhosus toxic substances I. Phenomenon of local skin reactivity to B typhosus culture filtrate. J. Exp. Med 38:247-268.
37. Siegel, S. 1956 Nonparametric statistics for the behavioral sciences, p 116-136, 229-238. McGraw-Hill International Book Co , New York
38. Snedecor, G. W., and W. G. Cochran. 1980. Statistical methods, vol. 7, p. 177-195 The Iowa State University Press, Ames.
39. Suffredini, A. F., R. E. Fromm, M. M. Parker, M. Brenner, J. A. Kovacs, R. A. Wesley, and J. E. Parrillo. 1989. The cardiovascular response of normal humans to administration of endotoxin. N. Engl. J Med 321:280-287.
40. Suffredini, A. F., P. C. Harpel, and J. E. Parrillo. 1989. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl. J. Med. 320:1165-1172.
41. Taveira da Silva, A. M., H. Kaulbach, F. Chuidian, D. Lambert, A. F. Suffredini, and R. L. Danner. 1993. Shock and multiple organ dysfunction caused by self-administration of R595 Salmonella minnesota endotoxin. N. Engl. J. Med 328:1457-1460.
42. Tesh, V. L., and D. C. Morrison. 1988. The interaction of Escherichia coli with normal human serum factors affecting the capacity of serum to mediate lipopolysaccharide release. Microb. Pathog. 4:175-187.
43. Thomas, L. L., A. Sturk, H. R. Buller, J. W. Ten Cate, R. E. Spijker, and H. Ten Cate. 1984. Comparative investigation of a quantitative chromogenic endotoxin assay and blood cultures. Am. J. Clin. Pathol. 82:203-206
44. Thomas, L. L. M., A. Sturk, L. H. Kahle, and J. W. Ten Cate. 1981. Quantitative endotoxin determination in blood with a chromogenic substrate. Clin. Chem. Acta 116:63-68.
45. Tomasulo, P. A., J. Levin, P. A. Murphy, and J. A. Winkelstein. 1977, Biological activities of tritiated endotoxins. correlation of the limulus lysate assay with rabbit pyrogen and complement-activation assays for endotoxin J. Lab. Clin. Med 89:308-315.
46. van Deventer, S. J. H., J. W. Ten Cate, and G. N. J. Ty Gat. 1988 Intestinal endotoxemia: clinical significance. Gastroenterology 94:825-831
47. Young, L. S., P. Stevens, and B. Kaiser. 1982. Gram-negative pathogens in septicemic infections. Scand. J. Infect. Dis. 31:78-94.